SAMANTHA DEBERRY: Open Payments
NPI 1528651395 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 7 payments from 5 companies in 2025. Trend: 2023 $2,750 · 2024 $3,283 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $245 |
| Gilead Sciences, Inc. | 1 | $148 |
| Stemline Therapeutics Inc. | 2 | $128 |
| Daiichi Sankyo Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $29 |
Products named: Orserdu, Enhertu, DATROWAY, IMBRUVICA.
Industry payments across AZ — which companies pay providers there.
